2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1750843983 MD
Verify on CMS →

Stephanie Midtling, MD

Glaucoma Specialist (Ophthalmology) Physician in La Jolla, California.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 356 in Glaucoma Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
219
Medicare Part D claims · 94 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
54%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$274.37
4 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Stephanie Midtling, MD filed 219 Medicare Part D claims in 2023 as a Glaucoma Specialist (Ophthalmology) Physician in La Jolla, California, prescribing 54% generic.

219
Part D claims, 2023
54%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Stephanie Midtling, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

219 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic, not verified)

Stephanie Midtling, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Stephanie Midtling, MD?

Quality data not reported

NPI registry status

Active

Issued 04/05/2019

NPI 1750843983

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

356 US NPIs in this specialty

Medicare Part D claims

219 93% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

Specialty distribution in California

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among California providers

California providers
Behavior Technician - 17.3%Behavior Technician17.3%Marriage & Family Therapist - 5.5%Marriage & Family Therapist5.5%Student in an Organized Health Care Education/Training Program - 5%Student in an Organized Health Care Education/Training Program5%Mental Health Counselor - 3.9%Mental Health Counselor3.9%Pharmacist - 3.5%Pharmacist3.5%Clinical Social Worker - 3.1%Clinical Social Worker3.1%Glaucoma Specialist (Ophthalmology) Physician - 0%Glaucoma Specialist (Ophthalmology) Physician0%
Largest specialties in California (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Glaucoma Specialist (Ophthalmology) Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Stephanie Midtling, MD appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding MD credentials at 9850 GENESEE AVE STE 310, La Jolla, CA, 92037, with a listed phone of (800) 898-2020. NPI 1750843983 was issued on 04/05/2019.

Medicare Part D records for calendar year 2023 show 219 prescription claims written by this provider, covering 94 Medicare beneficiaries and totaling roughly $15K in drug spend, split 46% brand-name and 54% generic by claim count.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 356 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

9850 GENESEE AVE STE 310
La Jolla, CA 92037

Provider Details

NPI 1750843983
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials MD
Gender Female
NPI Issued 04/05/2019

Hospital and facility affiliations

Facilities where Stephanie Midtling, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Retina Institute OF California Medical Group, A California Medical Par
La Jolla, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Stephanie Midtling, MD. Source: openpaymentsdata.cms.gov.

Total received

$274

Largest payer

Glaukos Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - California MBC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Stephanie Midtling, MD. To verify Stephanie Midtling, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Stephanie Midtling, MD - brand share 46.0%
Glaucoma Specialist (Ophthalmology) Physician average

46% brand-name claims vs 54% generic, on 219 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

219
Total Claims
$15K
Total Drug Cost
94
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
322
Total Day Supply
8,517
Brand vs Generic
46% brand / 54% generic
Brand Drug Cost
$11K
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
2.05
Gender Split
63% female / 37% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Stephanie Midtling, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
43
Prednisolone Acetate
40
Brimonidine Tartrate
33
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
30
Moxifloxacin
Moxifloxacin Hcl
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How Stephanie Midtling, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

356
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

Stephanie Midtling, MD's 219 claims are below the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Midtling.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Glaucoma Specialist (Ophthalmology) Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Stephanie Midtling, MD's specialty?
Stephanie Midtling, MD specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in La Jolla, California. Credentials: MD.
How much does Stephanie Midtling, MD prescribe under Medicare Part D?
In 2023, Stephanie Midtling, MD wrote 219 Medicare Part D claims totaling $15K in drug costs for 94 beneficiaries.
Where is Stephanie Midtling, MD located?
Stephanie Midtling, MD is located at 9850 GENESEE AVE STE 310, La Jolla, CA, 92037. Phone: (800) 898-2020.
What is Stephanie Midtling, MD's NPI number?
Stephanie Midtling, MD's National Provider Identifier (NPI) is 1750843983, issued on 04/05/2019.
Does Stephanie Midtling, MD prescribe more brand-name or generic drugs?
Stephanie Midtling, MD's prescribing is 46% brand-name and 54% generic drugs by claim count, with $11K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 356 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does Stephanie Midtling, MD prescribe most often?
Based on 2023 Medicare Part D data, Stephanie Midtling, MD's most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Stephanie Midtling, MD accept Medicare?
Stephanie Midtling, MD appears in CMS Medicare data with 219 Part D claims and 94 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Stephanie Midtling, MD's credentials?
Stephanie Midtling, MD's NPI is 1750843983 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.